These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 34340186)

  • 21. Identification of Molecular and Genetic Resistance Mechanisms in a Candida auris Isolate in a Tertiary Care Center in Türkiye.
    Erturk Sengel B; Ekren BY; Sayin E; Cerikcioglu N; Sezerman U; Odabasi Z
    Mycopathologia; 2023 Dec; 188(6):929-936. PubMed ID: 37639054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.
    Asadzadeh M; Mokaddas E; Ahmad S; Abdullah AA; de Groot T; Meis JF; Shetty SA
    Mycoses; 2022 Mar; 65(3):331-343. PubMed ID: 34953089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal Dissemination of
    Amadesi S; Palombo M; Bovo F; Liberatore A; Vecchi E; Cricca M; Lazzarotto T; Ambretti S; Gaibani P
    Microb Drug Resist; 2024 Jan; 30(1):50-54. PubMed ID: 37851491
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candida auris in Greek healthcare facilities: Active surveillance results on first cases and outbreaks from eleven hospitals within Attica region.
    Politi L; Vrioni G; Hatzianastasiou S; Lada M; Martsoukou M; Sipsas NV; Chini M; Baka V; Kafkoula E; Masgala A; Pirounaki M; Michailidis C; Chrysos G; Zarkotou O; Mamali V; Papastamopoulos V; Saroglou G; Pournaras S; Meletiadis J; Karakasiliotis I; Karachalios S; Smilakou S; Skandami V; Orfanidou M; Argyropoulou A; Tsakris A; Kontopidou F;
    J Mycol Med; 2024 Jun; 34(2):101477. PubMed ID: 38574412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 28. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital.
    Ruiz-Gaitán A; Moret AM; Tasias-Pitarch M; Aleixandre-López AI; Martínez-Morel H; Calabuig E; Salavert-Lletí M; Ramírez P; López-Hontangas JL; Hagen F; Meis JF; Mollar-Maseres J; Pemán J
    Mycoses; 2018 Jul; 61(7):498-505. PubMed ID: 29655180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years.
    Mulet-Bayona JV; Cancino-Muñoz I; Salvador-García C; Tormo-Palop N; Guna-Serrano MDR; Ferrer-Gómez C; Melero-García M; González-Candelas F; Gimeno-Cardona C
    Mycoses; 2024 Aug; 67(8):e13776. PubMed ID: 39086009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four genomic clades of Candida auris identified in Canada, 2012-2019.
    De Luca DG; Alexander DC; Dingle TC; Dufresne PJ; Hoang LM; Kus JV; Schwartz IS; Mulvey MR; Bharat A
    Med Mycol; 2022 Jan; 60(1):. PubMed ID: 34910140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation.
    Corzo-Leon DE; Peacock M; Rodriguez-Zulueta P; Salazar-Tamayo GJ; MacCallum DM
    Med Mycol; 2021 Jul; 59(7):664-671. PubMed ID: 33305313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Characterization of
    Reslan L; Araj GF; Finianos M; El Asmar R; Hrabak J; Dbaibo G; Bitar I
    Front Microbiol; 2021; 12():770635. PubMed ID: 35145489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
    Iguchi S; Itakura Y; Yoshida A; Kamada K; Mizushima R; Arai Y; Uzawa Y; Kikuchi K
    J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic epidemiology and antifungal-resistant characterization of
    Misas E; Escandón PL; Gade L; Caceres DH; Hurst S; Le N; Min B; Lyman M; Duarte C; Chow NA
    mSphere; 2024 Feb; 9(2):e0057723. PubMed ID: 38299868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
    Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.
    Jacobs SE; Jacobs JL; Dennis EK; Taimur S; Rana M; Patel D; Gitman M; Patel G; Schaefer S; Iyer K; Moon J; Adams V; Lerner P; Walsh TJ; Zhu Y; Anower MR; Vaidya MM; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0005322. PubMed ID: 35770999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida auris in Singapore: Genomic epidemiology, antifungal drug resistance, and identification using the updated 8.01 VITEK
    Tan YE; Teo JQ; Rahman NBA; Ng OT; Kalisvar M; Tan AL; Koh TH; Ong RTH
    Int J Antimicrob Agents; 2019 Dec; 54(6):709-715. PubMed ID: 31600556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited
    Healey KR; Kordalewska M; Jiménez Ortigosa C; Singh A; Berrío I; Chowdhary A; Perlin DS
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility.
    Williamson B; Wilk A; Guerrero KD; Mikulski TD; Elias TN; Sawh I; Cancino-Prado G; Gardam D; Heath CH; Govender NP; Perlin DS; Kordalewska M; Healey KR
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0162421. PubMed ID: 34633842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.